
Sign up to save your podcasts
Or


Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.
By The European Committee for Treatment and Research in Multiple Sclerosis4.5
22 ratings
Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress.

291 Listeners

50 Listeners

28,423 Listeners

112,060 Listeners

149 Listeners

867 Listeners

50 Listeners

5,458 Listeners

6,076 Listeners

124 Listeners

2,061 Listeners

82 Listeners